Germline pathogenic variants among high hereditary risk patients with breast and ovarian cancer and unaffected subjects in Lebanese Arab women

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 12

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

Figures (1-2)

Tables (1-5)

Sum=119

Publishing Process of This Article

Item

Count

Browse

Download

Sum=3

Dec 24, 2024 (publication date) through Oct 28, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Oncol. Dec 24, 2024; 15(12): 1481-1490
Published online Dec 24, 2024. doi: 10.5306/wjco.v15.i12.1481

Table 3 Genetic testing results for patients diagnosed with breast and/or ovarian cancer

BRCA: Breast cancer susceptibility gene.

Citation: Moukadem HA, Fakhreddine MA, Assaf N, Safi N, Al Masry A, Al Darazi M, Mahfouz R, El Saghir NS. Germline pathogenic variants among high hereditary risk patients with breast and ovarian cancer and unaffected subjects in Lebanese Arab women. World J Clin Oncol 2024; 15(12): 1481-1490
URL: https://www.wjgnet.com/2218-4333/full/v15/i12/1481.htm
DOI: https://dx.doi.org/10.5306/wjco.v15.i12.1481